Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Losartan Treatment on Matrix Metalloproteinase Levels and Outcomes in Bicuspid Aortic Valve Patients

NCT01390181 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01390181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01390181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Losartan Treatment on Matrix Metalloproteinase Levels and Outcomes in Bicuspid Aortic Valve Patients
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2011
Completion date
January 31, 2014
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bicuspid aortic valve, thoracic aortic aneurysm